A phase I trial of cyclosporine for hospitalized patients with COVID-19

A phase I trial of cyclosporine for hospitalized patients with COVID-19

BACKGROUND COVID-19 remains a global health emergency with limited treatment options, lagging vaccine rates, and inadequate healthcare resources in the face of an ongoing calamity. The disease is characterized by immune dysregulation and cytokine storm. Cyclosporine A (CSA) is a calcineurin inhibito...

Full description

Bibliographic Details
Main Authors:	Emily A. Blumberg, Julia Han Noll, Pablo Tebas, Joseph A. Fraietta, Ian Frank, Amy Marshall, Anne Chew, Elizabeth A. Veloso, Alison Carulli, Walter Rogal, Avery L. Gaymon, Aliza H. Schmidt, Tiffany Barnette, Renee Jurek, Rene Martins, Briana M. Hudson, Kalyan Chavda, Christina M. Bailey, Sarah E. Church, Hooman Noorchashm, Wei-Ting Hwang, Carl H. June, Elizabeth O. Hexner
Format:	Article
Language:	English
Published:	American Society for Clinical investigation 2022-06-01
Series:	JCI Insight
Subjects:	COVID-19
Online Access:	https://doi.org/10.1172/jci.insight.155682

Similar Items

Cyclosporine
by: Russell, N, et al.
Published: (2008)

Cyclosporine
by: Nahide Onsun
Published: (2022-04-01)

The controversial early history of cyclosporin
by: K Heusler, et al.
Published: (2001-06-01)

Structure of Cyclosporine and Its Metabolites: Total Synthesis of Cyclosporine Metabolites Formed by Oxidation at Positions 4 and 9 of Cyclosporine. Preparation of Leucine-4-cyclosporine, (?-Hydroxy)-N-methyl-leucine-9-cyclosporine and Leucine-4-(?-hydroxy)-N-methyl-leucine-9-cyclosporine
by: Roland M. Wenger, et al.
Published: (1992-07-01)

Efficacy and Safety of 0.1% Cyclosporine versus 2% Cyclosporine in the Treatment of Severe Vernal Keratoconjunctivitis in Children
by: Bourcier T, et al.
Published: (2022-10-01)

Effect of Fosfomycin on Cyclosporine Nephrotoxicity
by: Juan Antonio Ortega-Trejo, et al.
Published: (2020-10-01)

Cyclosporine in cholinergic itch
by: Sumit Sehgal, et al.
Published: (2022-01-01)

The cyclosporine syringe: A pragmatic approach for accurate calibration of cyclosporine dosing in children
by: Sandipan Dhar, et al.
Published: (2021-01-01)

CYCLOSPORINE IN TREATMENT OF SEVERE ATOPIC DERMATITIS IN CHILDREN
by: A.A. Alekseeva
Published: (2010-01-01)

CYCLOSPORINE IN TREATMENT OF SEVERE ATOPIC DERMATITIS IN CHILDREN
by: A.A. Alekseeva
Published: (2010-09-01)

Assessment of the efficiency of cyclosporine use in psoriasis
by: Kruglova L.S., et al.
Published: (2017-09-01)

Successful use of cyclosporine as treatment for eosinophilic cystitis: a case report
by: Sohaib Aleem, et al.
Published: (2016-01-01)

Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
by: Sahier O El-Khashab, et al.
Published: (2019-01-01)

Modifying cyclosporine associated renal allograft dysfunction
by: Mohapatra N, et al.
Published: (2009-01-01)

Recalcitrant pyoderma gangrenosum treated with cyclosporine in an infant
by: Teki Satya Sri, et al.
Published: (2016-01-01)

Clinical efficiency of cyclosporine in chronic idiopathic urticaria in adults
by: V.I. Petrov, et al.
Published: (2010-06-01)

EFFECTIVENESS OF CYCLOSPORINE IN SYSTEMIC TYPE OF JUVENILE IDIOPATHIC ARTHRITIS
by: V.A. Kel’tsev, et al.
Published: (2010-01-01)

EFFECTIVENESS OF CYCLOSPORINE IN SYSTEMIC TYPE OF JUVENILE IDIOPATHIC ARTHRITIS
by: V.A. Kel’tsev, et al.
Published: (2010-05-01)

ABC of monitoring drug therapy. Cyclosporin.
by: Reynolds, D, et al.
Published: (1992)

Nursing interventions in oral administration of Cyclosporine
by: Savić Maja
Published: (2023-01-01)

OF THE APPLICATION OF THE CYCLOSPORINE GENERICS IN THE PEDIATRIC RHEUMATOLOGY
by: S.I. Valieva, et al.
Published: (2007-01-01)

OF THE APPLICATION OF THE CYCLOSPORINE GENERICS IN THE PEDIATRIC RHEUMATOLOGY
by: S.I. Valieva, et al.
Published: (2007-07-01)

CYCLOSPORIN A IN THERAPY FOR JUVENILE ARTHRITIS
by: E S Fedorov, et al.
Published: (2010-06-01)

Cyclosporine-induced childhood generalized hypertrichosis,
by: Karilena Fernandes Souza, et al.
Published: (2020-07-01)

Development of the force field for cyclosporine A
by: Tsutomu Yamane, et al.
Published: (2022-12-01)

Comparison of two commercial cyclosporin assays
by: Vučeljić Marina, et al.
Published: (2007-01-01)

Can we predict the response to cyclosporine?
by: J. Hinojosa del Val, et al.

Effect of Erythromycin on the Intestinal Transport of Cyclosporine
by: P Zakeri Milani,, et al.
Published: (2009-06-01)

Cyclosporine Neoral: A Local Experience
by: Nampoory Mangalathillam, et al.
Published: (1999-01-01)

Cyclosporine-induced multiple sebaceous hyperplasia
by: Yun-Wen Chiu, et al.
Published: (2017-03-01)

The role of cyclosporine A on the periodontal tissues
by: Mallappa Jayasheela, et al.
Published: (2013-01-01)

Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome
by: A V Kokhno, et al.
Published: (2010-08-01)

Cyclosporin a disrupts notch signaling and vascular lumen maintenance.
by: Raghav Pandey, et al.
Published: (2015-01-01)

The cyclosporine transdermal transfer possibility study on model systems
by: E. G. Kuznetsova, et al.
Published: (2019-05-01)

The Effect of Particle Size on the Absorption of Cyclosporin A Nanosuspensions
by: Sun W, et al.
Published: (2022-04-01)

TREATMENT OF CHILDREN WITH FOCAL SEGMENTAL GLOMERULAR SCLEROSIS WITH CYCLOSPORINE A
by: O.V. Komarova, et al.
Published: (2009-09-01)

TREATMENT OF CHILDREN WITH FOCAL SEGMENTAL GLOMERULAR SCLEROSIS WITH CYCLOSPORINE A
by: O.V. Komarova, et al.
Published: (2009-01-01)

Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment
by: Mona M. A. Abdel-Mottaleb, et al.
Published: (2023-01-01)

Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: A prospective study
by: Shaveta Singla, et al.
Published: (2019-01-01)

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
by: Periman LM, et al.
Published: (2020-12-01)